REFACTO
Biological
PFIZER INC.
Total Payments
$208,973
Transactions
6
Doctors
2
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $50,000 | 1 | 0 |
| 2018 | $666.66 | 1 | 1 |
| 2017 | $158,306 | 4 | 2 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $205,331 | 2 | 98.3% |
| Consulting Fee | $3,642 | 4 | 1.7% |
Payments by Type
Research
$205,331
2 transactions
General
$3,642
4 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| HIGH RESOLUTION POINTOFCARE MUSCULOSKELETAL ULTRASOUND MSKUS FOR DIAGNOSTIC AND INTERVENTIONAL ADVANCEMENT OF THE MANAGEMENT OF ADULT HEMOPHILIC ARTHROPATHY | PFIZER INC. | $205,331 | 0 |
Top Doctors Receiving Payments for REFACTO
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | La Jolla, CA | $205,331 | 2 |
| Carol Kasper | — | Pasadena, CA | $2,667 | 3 |
| , MD | Pediatric Hematology-Oncology | Philadelphia, PA | $975.00 | 1 |
Ad
Manufacturing Companies
- PFIZER INC. $208,973
Product Information
- Type Biological
- Total Payments $208,973
- Total Doctors 2
- Transactions 6
About REFACTO
REFACTO is a biological associated with $208,973 in payments to 2 healthcare providers, recorded across 6 transactions in the CMS Open Payments database. The primary manufacturer is PFIZER INC..
Payment data is available from 2017 to 2019. In 2019, $50,000 was paid across 1 transactions to 0 doctors.
The most common payment nature for REFACTO is "Unspecified" ($205,331, 98.3% of total).
REFACTO is associated with 1 research study, including "HIGH RESOLUTION POINTOFCARE MUSCULOSKELETAL ULTRASOUND MSKUS FOR DIAGNOSTIC AND INTERVENTIONAL ADVANCEMENT OF THE MANAGEMENT OF ADULT HEMOPHILIC ARTHROPATHY" ($205,331).